The controversy over clinical trial transparency exploded last week as the BMJ published a reanalysis of previously hidden data on an antidepressant drug called Paroxetine (or Paxil). Paxil was approved for adults in 1992 by the Food and Drug Administration (FDA), but...
In a further sign of an epochal change in medical research, the World Health Organization has renewed its call for researchers to report all the results from clinical trial research. While there has been great deal of discussion about why clinical trial registration...
After two years of deliberation, the Institute of Medicine, part of the National Academies of Science, has concluded that sharing data from clinical trials is clearly in the public interest. In a detailed report released on January 14, the IOM said the issue was not...
Page 1 of 11
Recent Comments